Clinical Trial Update: A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing switching from entecavir to tenofovir disoproxil fumarate in adults with chronic hepatitis B has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2020-01-02